News
Discover six of the top psychedelic companies developing novel drugs to expand the treatment scope for mental health ...
Planned strategic combination with Beckley Psytech expected to solidify position as global leader in transformative, ...
In people with traumatic brain injury, administering the psychedelic drug ibogaine seems to slow down brainwaves, which may ...
After his mother died, Jonanthan ‘Quest’ Brown dove into spirituality to overcome his grief. Now Heal, Homie is helping ...
With little evidence or regulatory oversight, some mushroom products claim to improve cognitive function while posing a risk ...
Vail Health’s Behavioral Health Innovation Center director testifies before Congress on psychedelics
Dr. Charles Raison, executive director of Vail Health’s Behavioral Health Innovation Center, spoke to the U.S. House of Representatives’ bipartisan Addiction, Treatment and Recovery Caucus in ...
Non-hallucinogenic neuroplastogens offer benefits over classical psychedelics, including simpler delivery, stronger IP protection, and patient tolerability, writes Enveric Biosciences CEO Joseph ...
From cellular repair to cognitive resilience, researchers are exploring how psychedelics could influence the biology of aging ...
Maryland’s psychedelics task force has come out with an initial report as it gathers information about various regulatory and ...
New federally funded research on the relationship between post-traumatic stress disorder and cannabis use in military ...
Robert F. Kennedy Jr.’s ‘Make America Healthy Again’ movement is taking off in red — and blue — states, even as health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results